BioCentury | Feb 25, 2021
Feb. 24 Quick Takes: ICON buying PRA in $12B CRO deal; plus venture rounds for Yisheng, Xilio, Truvian, Lyvgen, AmacaThera, and more
...platform. Staff Writer Hongjiang Li contributed to this report. Jeff Cranmer ICON plc PRA Health Sciences Yisheng Biopharma Co. Ltd. Xilio Therapeutics Inc. Truvian...